Brown JWL, Cunniffe NG, Prados F, Kanber B, et al. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet Neurol 2021;20:709-720.
PMID: 34418398